Monthly Archives: March 2012

Frankly speaking about the drug shortage (Part 4)

We are at the halfway point in this series!  Yet to come is today’s synopsis from the Food and Drug Administration (FDA) and in the final 2 entries, an opportunity to understand the thoughts of Pfizer (who manufactures both brand … Continue reading

Posted in Advocacy, Research, Treatment, Uncategorized | Leave a comment

Frankly speaking about the drug shortage (Part 3)

Thank you for coming back for part 3 of this discussion.  If you are new today, I would suggest you take a quick look at the previous blogs building up to today. So far, we have covered an overview of … Continue reading

Posted in Advocacy, Research, Treatment | Leave a comment

Frankly speaking about the drug shortage (Part 2)

Today’s discussion will focus on the comments made by Dr. Bruce Chabner, MD.  Dr. Chabner is Director of Clinical Research for the Massachusetts General Hospital Cancer Center and he is also Professor of Medicine at Harvard Medical School. He is … Continue reading

Posted in Uncategorized | Leave a comment

Frankly speaking about the drug shortage (Part 1)

Thank you in advance for your interest in this topic and for your commitment to reading a series of blogs which are required because of the nature of this important topic. On February 29 and March 1, 2012, I was … Continue reading

Posted in Advocacy, Research, Treatment | Leave a comment

Extending our learning and teaching

On February 23, 24, and 25, 2012, we were honored to take part in the 9th Annual Conference of the American Psychosocial Oncology Society (APOS) in Miami, FL.  The conference theme was:Reducing Health Disparities in Quality Cancer Care: Psychosocial Research, Practice, … Continue reading

Posted in Advocacy, CSC Happenings | Leave a comment